IP Library Granted Patent US 7,833,547
Granted Patent B2
US 7,833,547 · App. 11/015,857 · Granted Nov 16, 2010

Ibuprofen and narcotic analgesic compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,547
App. No.
11/015,857
Granted
Nov 16, 2010
Kind
B2
Abstract

Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising ibuprofen; a narcotic analgesic; colloidal silicon dioxide; a filler selected from the group consisting of microcrystalline cellulose and powdered cellulose; a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and sodium starch glycolate; a binder consisting of an akylhydroxy methylcellulose; a starch; and a lubricant. Also provided herein is a method of preparing a pharmaceutical tablet composition comprising: (a) Granulating ibuprofen, a narcotic analgesic, a first glidant, a first disintegrant, a binder, and starch to form granules wherein said granulating step comprises a wet granulation process; (b) blending the granules with extra-granular material comprised of a second glidant, a second disintegrant, a filler and starch to form a blend of granules and extra-granular material; and (c) compressing the blend into a tablet.

Claims (10)

1. A pharmaceutical composition comprising:

(a) an effective amount of ibuprofen wherein the weight of the ibuprofen is provided in a range, of the total weight of the tablet composition, of up to about 50%;

(b) an effective amount of hydrocodone;

(c) colloidal silicon dioxide provided in a range, by total weight of the tablet composition, of about 1.5% to about 2%;

(d) microcrystalline cellulose provided in a range, of the total weight of the tablet composition, of about 15% to about 25%;

(e) a disintegrant selected from the group consisting of croscarmellose sodium and crospovidone wherein the weight of the disintegrant is provided in a range, of the total weight of the tablet composition, of about 6 to about 8%;

(f) a binder consisting of an alkylhydroxy methylcellulose wherein the weight of the binder is provided in a range, of the total weight of the tablet composition, of about 3% to about 4%;

(g) corn starch wherein the weight of the corn starch is provided in a range, of the total weight of the tablet composition, of about 11 to about 17%; and

(h) a lubricant wherein the weight of the lubricant is provided in an amount less than 1% by weight of the total weight of the tablet, wherein not less than 70% of the ibuprofen or the hydrocodone is released at 30 minutes in 900 mL of pH phosphate buffer, at 37° C. using baskets at 150 revolutions per minute, wherein said composition has acceptable disintegration, dissolution and compression characteristics wherein the tablet has compression forces from 5 to 20 kN with no substantial change in the disintegration time of the tablet, and wherein said composition is substantially free of lactose.

2. The pharmaceutical composition of claim 1 , wherein 100% of the ibuprofen and the hydrocodone is released in 10 minutes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030716/0601 →